Chong Kun Dang Pharmaceutical Corp.

KOSE:A185750 Stock Report

Market Cap: ₩1.3t

Chong Kun Dang Pharmaceutical Balance Sheet Health

Financial Health criteria checks 5/6

Chong Kun Dang Pharmaceutical has a total shareholder equity of ₩826.5B and total debt of ₩209.5B, which brings its debt-to-equity ratio to 25.4%. Its total assets and total liabilities are ₩1,414.8B and ₩588.3B respectively. Chong Kun Dang Pharmaceutical's EBIT is ₩245.9B making its interest coverage ratio 373.5. It has cash and short-term investments of ₩393.3B.

Key information

25.4%

Debt to equity ratio

₩209.52b

Debt

Interest coverage ratio373.5x
Cash₩393.30b
Equity₩826.49b
Total liabilities₩588.33b
Total assets₩1.41t

Recent financial health updates

Recent updates

Investors Don't See Light At End Of Chong Kun Dang Pharmaceutical Corp.'s (KRX:185750) Tunnel

Jun 12
Investors Don't See Light At End Of Chong Kun Dang Pharmaceutical Corp.'s (KRX:185750) Tunnel

Chong Kun Dang Pharmaceutical (KRX:185750) Seems To Use Debt Rather Sparingly

May 27
Chong Kun Dang Pharmaceutical (KRX:185750) Seems To Use Debt Rather Sparingly

A Look At The Fair Value Of Chong Kun Dang Pharmaceutical Corp. (KRX:185750)

Apr 09
A Look At The Fair Value Of Chong Kun Dang Pharmaceutical Corp. (KRX:185750)

Does Chong Kun Dang Pharmaceutical (KRX:185750) Have A Healthy Balance Sheet?

Apr 19
Does Chong Kun Dang Pharmaceutical (KRX:185750) Have A Healthy Balance Sheet?

Here's Why I Think Chong Kun Dang Pharmaceutical (KRX:185750) Is An Interesting Stock

Apr 05
Here's Why I Think Chong Kun Dang Pharmaceutical (KRX:185750) Is An Interesting Stock

Declining Stock and Solid Fundamentals: Is The Market Wrong About Chong Kun Dang Pharmaceutical Corp. (KRX:185750)?

Mar 09
Declining Stock and Solid Fundamentals: Is The Market Wrong About Chong Kun Dang Pharmaceutical Corp. (KRX:185750)?

Estimating The Fair Value Of Chong Kun Dang Pharmaceutical Corp. (KRX:185750)

Feb 24
Estimating The Fair Value Of Chong Kun Dang Pharmaceutical Corp. (KRX:185750)

The Chong Kun Dang Pharmaceutical (KRX:185750) Share Price Is Up 112% And Shareholders Are Boasting About It

Feb 11
The Chong Kun Dang Pharmaceutical (KRX:185750) Share Price Is Up 112% And Shareholders Are Boasting About It

Is Chong Kun Dang Pharmaceutical Corp. (KRX:185750) An Attractive Dividend Stock?

Jan 27
Is Chong Kun Dang Pharmaceutical Corp. (KRX:185750) An Attractive Dividend Stock?

Does Chong Kun Dang Pharmaceutical (KRX:185750) Have A Healthy Balance Sheet?

Jan 12
Does Chong Kun Dang Pharmaceutical (KRX:185750) Have A Healthy Balance Sheet?

With EPS Growth And More, Chong Kun Dang Pharmaceutical (KRX:185750) Is Interesting

Dec 28
With EPS Growth And More, Chong Kun Dang Pharmaceutical (KRX:185750) Is Interesting

What Kind Of Shareholders Hold The Majority In Chong Kun Dang Pharmaceutical Corp.'s (KRX:185750) Shares?

Dec 09
What Kind Of Shareholders Hold The Majority In Chong Kun Dang Pharmaceutical Corp.'s (KRX:185750) Shares?

Could The Market Be Wrong About Chong Kun Dang Pharmaceutical Corp. (KRX:185750) Given Its Attractive Financial Prospects?

Nov 24
Could The Market Be Wrong About Chong Kun Dang Pharmaceutical Corp. (KRX:185750) Given Its Attractive Financial Prospects?

Financial Position Analysis

Short Term Liabilities: A185750's short term assets (₩956.4B) exceed its short term liabilities (₩502.4B).

Long Term Liabilities: A185750's short term assets (₩956.4B) exceed its long term liabilities (₩86.0B).


Debt to Equity History and Analysis

Debt Level: A185750 has more cash than its total debt.

Reducing Debt: A185750's debt to equity ratio has increased from 24.5% to 25.4% over the past 5 years.

Debt Coverage: A185750's debt is well covered by operating cash flow (153.3%).

Interest Coverage: A185750's interest payments on its debt are well covered by EBIT (373.5x coverage).


Balance Sheet


Discover healthy companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.